MLchartDataset catalogue

CHIR-265

Term · Oncology and biomedicine · MLC-T-ONC-001682

A substance being studied in the treatment of melanoma. CHIR-265 may block the growth of tumors and the growth of blood vessels from surrounding tissue to the tumor. It is a type of Raf kinase inhibitor and angiogenesis inhibitor.

Table 1. Record
IdentifierMLC-T-ONC-001682
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-001682",
  "term": "CHIR-265",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of melanoma. CHIR-265 may block the growth of tumors and the growth of blood vessels from surrounding tissue to the tumor. It is a type of Raf kinase inhibitor and angiogenesis inhibitor.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/chir-265/"
}

Record 4,725 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.